Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- PAT(Q) At Rs -7.35 cr has Fallen at -10600.0% (vs previous 4Q average)
- PBDIT(Q) Lowest at Rs -8.79 cr.
- PBT LESS OI(Q) Lowest at Rs -8.93 cr.
Stock is technically in a Mildly Bullish range
With ROE of 0.3, it has a Very Expensive valuation with a 2.5 Price to Book Value
Majority shareholders : Promoters
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Non Banking Financial Company (NBFC)
INR 204 Cr (Micro Cap)
NA (Loss Making)
21
0.00%
0.00
-6.39%
2.51
Total Returns (Price + Dividend) 
Latest dividend: 1.0000 per share ex-dividend date: Sep-07-2011
Risk Adjusted Returns v/s 
Returns Beta
News

Crescentis Capital Ltd Forms Death Cross, Signalling Potential Bearish Trend
Crescentis Capital Ltd, a micro-cap player in the Non Banking Financial Company (NBFC) sector, has recently formed a Death Cross—a technical pattern where the 50-day moving average crosses below the 200-day moving average. This development is widely regarded as a bearish signal, indicating a potential deterioration in the stock’s medium to long-term trend and raising concerns about sustained weakness ahead.
Read More
Crescentis Capital Ltd is Rated Sell
Crescentis Capital Ltd is rated Sell by MarketsMOJO, with this rating last updated on 20 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Som Datt Finance Corporation Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals
Som Datt Finance Corporation Ltd, a micro-cap player in the Non Banking Financial Company (NBFC) sector, has seen its investment rating downgraded from Hold to Sell as of 20 April 2026. This decision follows a comprehensive reassessment across four critical parameters: quality, valuation, financial trend, and technicals. Despite some positive quarterly results and market-beating returns over the past year, the downgrade reflects concerns over long-term fundamentals, expensive valuation metrics, and a shift in technical indicators.
Read More Announcements 
Unmodified Opinon
30-May-2026 | Source : BSEsubmission of Declaraion pursuant to Regulation 33(3)(d)
Announcement under Regulation 30 (LODR)-Newspaper Publication
30-May-2026 | Source : BSENewspaper Publication of Quarterly & Yearly Financial Results as on 31st March 2026
Compliances-Reg.24(A)-Annual Secretarial Compliance
29-May-2026 | Source : BSESubmission of Annual Secretarial Compliance Report received from the Secretarial Auditor for the Financial Year ended on March 31 2026
Corporate Actions 
No Upcoming Board Meetings
Crescentis Capital Ltd has declared 10% dividend, ex-date: 07 Sep 11
No Splits history available
No Bonus history available
Crescentis Capital Ltd has announced 7:10 rights issue, ex-date: 06 Jun 25
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Dr. Bhaskara Rao Bollineni (68.8%)
Soptex Developements Limited (1.45%)
20.11%
Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ
QoQ Growth in quarter ended Mar 2026 is -300.00% vs 1,330.77% in Dec 2025
QoQ Growth in quarter ended Mar 2026 is -717.65% vs 347.92% in Dec 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 4.83% vs -28.08% in Sep 2024
Growth in half year ended Sep 2025 is 8.71% vs -54.56% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 1,175.71% vs -93.86% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 346.06% vs -117.61% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is 149.01% vs -120.09% in Mar 2025
YoY Growth in year ended Mar 2026 is 53.32% vs -144.79% in Mar 2025